AustralieFrV1, PubMed, Curation, bibRecord, 001491

Implications of Plasmodium vivax Biology for Control, Elimination, and Research.

Identifieur interne : 001491 ( PubMed/Curation ); précédent : 001490; suivant : 001492

Implications of Plasmodium vivax Biology for Control, Elimination, and Research.

Auteurs : Piero L. Olliaro [Suisse] ; John W. Barnwell [Géorgie (pays)] ; Alyssa Barry [Australie] ; Kamini Mendis ; Ivo Mueller [Australie] ; John C. Reeder [Suisse] ; G Dennis Shanks [Australie] ; Georges Snounou [France] ; Chansuda Wongsrichanalai [Thaïlande]

Source :

The American journal of tropical medicine and hygiene [ 1476-1645 ] ; 2016.

RBID : pubmed:27799636

Descripteurs français

KwdFr :
- Antipaludiques (usage thérapeutique), Humains, Paludisme à Plasmodium vivax (), Paludisme à Plasmodium vivax (parasitologie), Paludisme à Plasmodium vivax (transmission), Plasmodium vivax (génétique), Plasmodium vivax (physiologie), Santé mondiale, Spécificité d'espèce, Variation génétique, Étapes du cycle de vie.
MESH :
- génétique : Plasmodium vivax.
- parasitologie : Paludisme à Plasmodium vivax.
- physiologie : Plasmodium vivax.
- usage thérapeutique : Antipaludiques, Paludisme à Plasmodium vivax.
- Humains, Paludisme à Plasmodium vivax, Santé mondiale, Spécificité d'espèce, Variation génétique, Étapes du cycle de vie.

English descriptors

KwdEn :
- Antimalarials (therapeutic use), Genetic Variation, Global Health, Humans, Life Cycle Stages, Malaria, Vivax (parasitology), Malaria, Vivax (prevention & control), Malaria, Vivax (transmission), Plasmodium vivax (genetics), Plasmodium vivax (physiology), Species Specificity.
MESH :
- chemical , therapeutic use : Antimalarials.
- genetics : Plasmodium vivax.
- parasitology : Malaria, Vivax.
- physiology : Plasmodium vivax.
- prevention & control : Malaria, Vivax.
- transmission : Malaria, Vivax.
- Genetic Variation, Global Health, Humans, Life Cycle Stages, Species Specificity.

Abstract

This paper summarizes our current understanding of the biology of Plasmodium vivax, how it differs from Plasmodium falciparum, and how these differences explain the need for P. vivax-tailored interventions. The article further pinpoints knowledge gaps where investments in research are needed to help identify and develop such specific interventions. The principal obstacles to reduce and eventually eliminate P. vivax reside in 1) its higher vectorial capacity compared with P. falciparum due to its ability to develop at lower temperature and over a shorter sporogonic cycle in the vector, allowing transmission in temperate zones and making it less sensitive to vector control measures that are otherwise effective on P. falciparum; 2) the presence of dormant liver forms (hypnozoites), sustaining multiple relapsing episodes from a single infectious bite that cannot be diagnosed and are not susceptible to any available antimalarial except primaquine, with routine deployment restricted by toxicity; 3) low parasite densities, which are difficult to detect with current diagnostics leading to missed diagnoses and delayed treatments (and protracted transmission), coupled with 4) transmission stages (gametocytes) occurring early in acute infections, before infection is diagnosed.

DOI: 10.4269/ajtmh.16-0160
PubMed: 27799636

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001513

Links to Exploration step

pubmed:27799636

Curation

No country items

Kamini Mendis

<affiliation><nlm:affiliation>Independent Consultant, Colombo 5. Sri Lanka.</nlm:affiliation>
<wicri:noCountry code="subField">Colombo 5</wicri:noCountry>
</affiliation>

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Implications of Plasmodium vivax Biology for Control, Elimination, and Research.</title>
<author><name sortKey="Olliaro, Piero L" sort="Olliaro, Piero L" uniqKey="Olliaro P" first="Piero L" last="Olliaro">Piero L. Olliaro</name>
<affiliation wicri:level="1"><nlm:affiliation>UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland. olliarop@who.int.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Barnwell, John W" sort="Barnwell, John W" uniqKey="Barnwell J" first="John W" last="Barnwell">John W. Barnwell</name>
<affiliation wicri:level="1"><nlm:affiliation>Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Barry, Alyssa" sort="Barry, Alyssa" uniqKey="Barry A" first="Alyssa" last="Barry">Alyssa Barry</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Division of Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Melbourne</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mendis, Kamini" sort="Mendis, Kamini" uniqKey="Mendis K" first="Kamini" last="Mendis">Kamini Mendis</name>
<affiliation><nlm:affiliation>Independent Consultant, Colombo 5. Sri Lanka.</nlm:affiliation>
<wicri:noCountry code="subField">Colombo 5</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Mueller, Ivo" sort="Mueller, Ivo" uniqKey="Mueller I" first="Ivo" last="Mueller">Ivo Mueller</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Division of Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Melbourne</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Reeder, John C" sort="Reeder, John C" uniqKey="Reeder J" first="John C" last="Reeder">John C. Reeder</name>
<affiliation wicri:level="1"><nlm:affiliation>UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Shanks, G Dennis" sort="Shanks, G Dennis" uniqKey="Shanks G" first="G Dennis" last="Shanks">G Dennis Shanks</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Population Health, University of Queensland, Brisbane, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Population Health, University of Queensland, Brisbane</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Snounou, Georges" sort="Snounou, Georges" uniqKey="Snounou G" first="Georges" last="Snounou">Georges Snounou</name>
<affiliation wicri:level="1"><nlm:affiliation>Sorbonne Universités, UPMC Univ Paris 06, UPMC UMRS CR7, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Sorbonne Universités, UPMC Univ Paris 06, UPMC UMRS CR7, Paris</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wongsrichanalai, Chansuda" sort="Wongsrichanalai, Chansuda" uniqKey="Wongsrichanalai C" first="Chansuda" last="Wongsrichanalai">Chansuda Wongsrichanalai</name>
<affiliation wicri:level="1"><nlm:affiliation>Independent Scholar, Bangkok, Thailand.</nlm:affiliation>
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Independent Scholar, Bangkok</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27799636</idno>
<idno type="pmid">27799636</idno>
<idno type="doi">10.4269/ajtmh.16-0160</idno>
<idno type="wicri:Area/PubMed/Corpus">001513</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001513</idno>
<idno type="wicri:Area/PubMed/Curation">001491</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001491</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Implications of Plasmodium vivax Biology for Control, Elimination, and Research.</title>
<author><name sortKey="Olliaro, Piero L" sort="Olliaro, Piero L" uniqKey="Olliaro P" first="Piero L" last="Olliaro">Piero L. Olliaro</name>
<affiliation wicri:level="1"><nlm:affiliation>UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland. olliarop@who.int.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Barnwell, John W" sort="Barnwell, John W" uniqKey="Barnwell J" first="John W" last="Barnwell">John W. Barnwell</name>
<affiliation wicri:level="1"><nlm:affiliation>Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Barry, Alyssa" sort="Barry, Alyssa" uniqKey="Barry A" first="Alyssa" last="Barry">Alyssa Barry</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Division of Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Melbourne</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mendis, Kamini" sort="Mendis, Kamini" uniqKey="Mendis K" first="Kamini" last="Mendis">Kamini Mendis</name>
<affiliation><nlm:affiliation>Independent Consultant, Colombo 5. Sri Lanka.</nlm:affiliation>
<wicri:noCountry code="subField">Colombo 5</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Mueller, Ivo" sort="Mueller, Ivo" uniqKey="Mueller I" first="Ivo" last="Mueller">Ivo Mueller</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Division of Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Melbourne</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Reeder, John C" sort="Reeder, John C" uniqKey="Reeder J" first="John C" last="Reeder">John C. Reeder</name>
<affiliation wicri:level="1"><nlm:affiliation>UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Shanks, G Dennis" sort="Shanks, G Dennis" uniqKey="Shanks G" first="G Dennis" last="Shanks">G Dennis Shanks</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Population Health, University of Queensland, Brisbane, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Population Health, University of Queensland, Brisbane</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Snounou, Georges" sort="Snounou, Georges" uniqKey="Snounou G" first="Georges" last="Snounou">Georges Snounou</name>
<affiliation wicri:level="1"><nlm:affiliation>Sorbonne Universités, UPMC Univ Paris 06, UPMC UMRS CR7, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Sorbonne Universités, UPMC Univ Paris 06, UPMC UMRS CR7, Paris</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wongsrichanalai, Chansuda" sort="Wongsrichanalai, Chansuda" uniqKey="Wongsrichanalai C" first="Chansuda" last="Wongsrichanalai">Chansuda Wongsrichanalai</name>
<affiliation wicri:level="1"><nlm:affiliation>Independent Scholar, Bangkok, Thailand.</nlm:affiliation>
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Independent Scholar, Bangkok</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">The American journal of tropical medicine and hygiene</title>
<idno type="eISSN">1476-1645</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antimalarials (therapeutic use)</term>
<term>Genetic Variation</term>
<term>Global Health</term>
<term>Humans</term>
<term>Life Cycle Stages</term>
<term>Malaria, Vivax (parasitology)</term>
<term>Malaria, Vivax (prevention & control)</term>
<term>Malaria, Vivax (transmission)</term>
<term>Plasmodium vivax (genetics)</term>
<term>Plasmodium vivax (physiology)</term>
<term>Species Specificity</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antipaludiques (usage thérapeutique)</term>
<term>Humains</term>
<term>Paludisme à Plasmodium vivax ()</term>
<term>Paludisme à Plasmodium vivax (parasitologie)</term>
<term>Paludisme à Plasmodium vivax (transmission)</term>
<term>Plasmodium vivax (génétique)</term>
<term>Plasmodium vivax (physiologie)</term>
<term>Santé mondiale</term>
<term>Spécificité d'espèce</term>
<term>Variation génétique</term>
<term>Étapes du cycle de vie</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antimalarials</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Plasmodium vivax</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Plasmodium vivax</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr"><term>Paludisme à Plasmodium vivax</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitology" xml:lang="en"><term>Malaria, Vivax</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Plasmodium vivax</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Plasmodium vivax</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Malaria, Vivax</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Malaria, Vivax</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antipaludiques</term>
<term>Paludisme à Plasmodium vivax</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Genetic Variation</term>
<term>Global Health</term>
<term>Humans</term>
<term>Life Cycle Stages</term>
<term>Species Specificity</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
<term>Paludisme à Plasmodium vivax</term>
<term>Santé mondiale</term>
<term>Spécificité d'espèce</term>
<term>Variation génétique</term>
<term>Étapes du cycle de vie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This paper summarizes our current understanding of the biology of Plasmodium vivax, how it differs from Plasmodium falciparum, and how these differences explain the need for P. vivax-tailored interventions. The article further pinpoints knowledge gaps where investments in research are needed to help identify and develop such specific interventions. The principal obstacles to reduce and eventually eliminate P. vivax reside in 1) its higher vectorial capacity compared with P. falciparum due to its ability to develop at lower temperature and over a shorter sporogonic cycle in the vector, allowing transmission in temperate zones and making it less sensitive to vector control measures that are otherwise effective on P. falciparum; 2) the presence of dormant liver forms (hypnozoites), sustaining multiple relapsing episodes from a single infectious bite that cannot be diagnosed and are not susceptible to any available antimalarial except primaquine, with routine deployment restricted by toxicity; 3) low parasite densities, which are difficult to detect with current diagnostics leading to missed diagnoses and delayed treatments (and protracted transmission), coupled with 4) transmission stages (gametocytes) occurring early in acute infections, before infection is diagnosed.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27799636</PMID>
<DateCreated><Year>2016</Year>
<Month>11</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>05</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>05</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-1645</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>95</Volume>
<Issue>6 Suppl</Issue>
<PubDate><Year>2016</Year>
<Month>Dec</Month>
<Day>28</Day>
</PubDate>
</JournalIssue>
<Title>The American journal of tropical medicine and hygiene</Title>
<ISOAbbreviation>Am. J. Trop. Med. Hyg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Implications of Plasmodium vivax Biology for Control, Elimination, and Research.</ArticleTitle>
<Pagination><MedlinePgn>4-14</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.4269/ajtmh.16-0160</ELocationID>
<Abstract><AbstractText>This paper summarizes our current understanding of the biology of Plasmodium vivax, how it differs from Plasmodium falciparum, and how these differences explain the need for P. vivax-tailored interventions. The article further pinpoints knowledge gaps where investments in research are needed to help identify and develop such specific interventions. The principal obstacles to reduce and eventually eliminate P. vivax reside in 1) its higher vectorial capacity compared with P. falciparum due to its ability to develop at lower temperature and over a shorter sporogonic cycle in the vector, allowing transmission in temperate zones and making it less sensitive to vector control measures that are otherwise effective on P. falciparum; 2) the presence of dormant liver forms (hypnozoites), sustaining multiple relapsing episodes from a single infectious bite that cannot be diagnosed and are not susceptible to any available antimalarial except primaquine, with routine deployment restricted by toxicity; 3) low parasite densities, which are difficult to detect with current diagnostics leading to missed diagnoses and delayed treatments (and protracted transmission), coupled with 4) transmission stages (gametocytes) occurring early in acute infections, before infection is diagnosed.</AbstractText>
<CopyrightInformation>© The American Society of Tropical Medicine and Hygiene.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Olliaro</LastName>
<ForeName>Piero L</ForeName>
<Initials>PL</Initials>
<AffiliationInfo><Affiliation>UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland. olliarop@who.int.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Barnwell</LastName>
<ForeName>John W</ForeName>
<Initials>JW</Initials>
<AffiliationInfo><Affiliation>Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Barry</LastName>
<ForeName>Alyssa</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Division of Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Medical Biology, University of Melbourne, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mendis</LastName>
<ForeName>Kamini</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Independent Consultant, Colombo 5. Sri Lanka.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mueller</LastName>
<ForeName>Ivo</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Division of Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Institute of Global Health (ISGLOBAL), Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Reeder</LastName>
<ForeName>John C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo><Affiliation>UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Shanks</LastName>
<ForeName>G Dennis</ForeName>
<Initials>GD</Initials>
<AffiliationInfo><Affiliation>School of Population Health, University of Queensland, Brisbane, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Snounou</LastName>
<ForeName>Georges</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Sorbonne Universités, UPMC Univ Paris 06, UPMC UMRS CR7, Paris, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Centre d'Immunologie et de Maladies Infectieuses (CIMI)-Paris, Institut National de la Santé et de la Recherche Médicale (INSERM) U1135-Centre National de la Recherche Scientifique (CNRS) ERL 8255, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wongsrichanalai</LastName>
<ForeName>Chansuda</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Independent Scholar, Bangkok, Thailand.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>10</Month>
<Day>31</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Am J Trop Med Hyg</MedlineTA>
<NlmUniqueID>0370507</NlmUniqueID>
<ISSNLinking>0002-9637</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 1972 Sep;21(5):707-12</RefSource>
<PMID Version="1">4627547</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2015 May 07;9(5):e0003739</RefSource>
<PMID Version="1">25951184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2002 Jun;66(6):641-8</RefSource>
<PMID Version="1">12224567</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell. 1992 Jun 26;69(7):1213-26</RefSource>
<PMID Version="1">1617731</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Malar J. 2012 Mar 14;11:68</RefSource>
<PMID Version="1">22417572</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2015 Oct 27;12 (10 ):e1001891</RefSource>
<PMID Version="1">26505753</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2015 Apr 15;9(4):e0003634</RefSource>
<PMID Version="1">25874894</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Parasitol. 2012 Nov;42(12):1099-105</RefSource>
<PMID Version="1">23022617</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2012;6(9):e1814</RefSource>
<PMID Version="1">22970336</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2009 Aug;81(2):366-9</RefSource>
<PMID Version="1">19635900</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2015 Jan 08;11(1):e1004558</RefSource>
<PMID Version="1">25569250</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Adv Parasitol. 2012;80:151-201</RefSource>
<PMID Version="1">23199488</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Euro Surveill. 2011 Oct 20;16(42):null</RefSource>
<PMID Version="1">22027375</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Adv Parasitol. 2012;80:301-41</RefSource>
<PMID Version="1">23199491</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2009 Feb 1;199(3):445-50</RefSource>
<PMID Version="1">19090777</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2011 Dec;5(12):e1424</RefSource>
<PMID Version="1">22206027</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013 Nov 21;7(11):e2489</RefSource>
<PMID Version="1">24278487</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2 Suppl):97-106</RefSource>
<PMID Version="1">11425182</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5967-71</RefSource>
<PMID Version="1">20231434</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011 Mar 31;6(3):e18162</RefSource>
<PMID Version="1">21483865</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Adv Parasitol. 2013;81:77-131</RefSource>
<PMID Version="1">23384622</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Host Microbe. 2013 Jul 17;14(1):104-15</RefSource>
<PMID Version="1">23870318</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3200-3</RefSource>
<PMID Version="1">1565611</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2015 Jun 30;9(6):e0003872</RefSource>
<PMID Version="1">26125189</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Microbiol. 2009 May;7(5):341-54</RefSource>
<PMID Version="1">19369950</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parasitol Today. 1995 Mar;11(3):105-11</RefSource>
<PMID Version="1">15275362</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2003 Apr;68(4):410-2</RefSource>
<PMID Version="1">12875288</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Malar J. 2011 Oct 11;10:297</RefSource>
<PMID Version="1">21989376</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Microbiol Rev. 1992 Jan;5(1):26-35</RefSource>
<PMID Version="1">1735093</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Infect Dis. 2013 Feb;17(2):e125-8</RefSource>
<PMID Version="1">23098813</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Adv Parasitol. 2012;80:113-50</RefSource>
<PMID Version="1">23199487</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 1989 Nov 18;2(8673):1183-4</RefSource>
<PMID Version="1">2572903</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Malar J. 2016 Feb 09;15:80</RefSource>
<PMID Version="1">26861780</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Parasitol. 2007 Jun;93(3):627-33</RefSource>
<PMID Version="1">17626355</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 1993 Jul-Aug;87(4):436-43</RefSource>
<PMID Version="1">8249075</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2012 Feb 15;205(4):680-3</RefSource>
<PMID Version="1">22194628</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2004 Jan 15;189(2):190-4</RefSource>
<PMID Version="1">14722882</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2014 Jun 05;8(6):e2882</RefSource>
<PMID Version="1">24901334</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Host Microbe. 2015 Apr 8;17(4):526-35</RefSource>
<PMID Version="1">25800544</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2014 Mar;20(3):307-12</RefSource>
<PMID Version="1">24509527</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2008 Jun 17;5(6):e128</RefSource>
<PMID Version="1">18563962</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013 Dec 05;7(12):e2569</RefSource>
<PMID Version="1">24340114</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2009 Sep;9(9):555-66</RefSource>
<PMID Version="1">19695492</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2005 Jun;72(6):666-74</RefSource>
<PMID Version="1">15964948</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013 Sep 05;7(9):e2403</RefSource>
<PMID Version="1">24040428</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2004 Nov 1;190(9):1556-62</RefSource>
<PMID Version="1">15478059</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Microbiol Rev. 2013 Jan;26(1):36-57</RefSource>
<PMID Version="1">23297258</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Adv Parasitol. 2012;80:271-300</RefSource>
<PMID Version="1">23199490</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2007 Apr 1;195(7):934-41</RefSource>
<PMID Version="1">17330782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2016 Aug;48(8):953-8</RefSource>
<PMID Version="1">27348298</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Euro Surveill. 2012 Nov 22;17(47):null</RefSource>
<PMID Version="1">23231856</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2012 Dec 1;206(11):1771-80</RefSource>
<PMID Version="1">22966124</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2012 Sep;44(9):1046-50</RefSource>
<PMID Version="1">22863733</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Mar 20;10(3):e0119475</RefSource>
<PMID Version="1">25793260</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pathog Glob Health. 2015 May;109(3):142-52</RefSource>
<PMID Version="1">25891915</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2013 Oct;13(10):900-6</RefSource>
<PMID Version="1">23809889</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2011 Jun;5(6):e1192</RefSource>
<PMID Version="1">21713024</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2008 Oct 9;455(7214):757-63</RefSource>
<PMID Version="1">18843361</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Microbiol Rev. 2011 Apr;24(2):377-410</RefSource>
<PMID Version="1">21482730</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Exp Parasitol. 2013 Jul;134(3):318-26</RefSource>
<PMID Version="1">23562882</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 1992 Mar-Apr;86(2):121-2</RefSource>
<PMID Version="1">1440763</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2012 Apr;17(4):414-22</RefSource>
<PMID Version="1">22296040</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2010 Feb 04;5(2):e9047</RefSource>
<PMID Version="1">20140220</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2016 Aug;48(8):959-64</RefSource>
<PMID Version="1">27348299</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):E191-200</RefSource>
<PMID Version="1">26715754</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2014 Aug 28;8(8):e3109</RefSource>
<PMID Version="1">25166263</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2008;3(10):e3366</RefSource>
<PMID Version="1">18846221</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008018" MajorTopicYN="N">Life Cycle Stages</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016780" MajorTopicYN="N">Malaria, Vivax</DescriptorName>
<QualifierName UI="Q000469" MajorTopicYN="Y">parasitology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010966" MajorTopicYN="N">Plasmodium vivax</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>02</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>09</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>11</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>5</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>11</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27799636</ArticleId>
<ArticleId IdType="pii">ajtmh.16-0160</ArticleId>
<ArticleId IdType="doi">10.4269/ajtmh.16-0160</ArticleId>
<ArticleId IdType="pmc">PMC5201222</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001491 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001491 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:27799636
   |texte=   Implications of Plasmodium vivax Biology for Control, Elimination, and Research.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:27799636" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Implications of Plasmodium vivax Biology for Control, Elimination, and Research.

Implications of Plasmodium vivax Biology for Control, Elimination, and Research.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Curation

No country items

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki